These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7625786

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J, Stone J, Andrews JM, Ashby JP, Wise R.
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [Abstract] [Full Text] [Related]

  • 23. Effect of lomefloxacin on theophylline pharmacokinetics.
    Nix DE, Norman A, Schentag JJ.
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1006-8. PubMed ID: 2675751
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
    Stratton CW, Weeks LS.
    Diagn Microbiol Infect Dis; 1989 Jul; 12(3 Suppl):29S-34S. PubMed ID: 2791495
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH, Harder S, Fuhr U, Wack C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [Abstract] [Full Text] [Related]

  • 28. Influence of lomefloxacin on the pharmacokinetics of theophylline.
    LeBel M, Vallée F, St-Laurent M.
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1254-6. PubMed ID: 2393286
    [Abstract] [Full Text] [Related]

  • 29. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
    Leroy A, Fillastre JP, Humbert G.
    Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
    [Abstract] [Full Text] [Related]

  • 30. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ, García I, Pascual A.
    Am J Med; 1992 Apr 06; 92(4A):48S-51S. PubMed ID: 1316071
    [Abstract] [Full Text] [Related]

  • 31. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E, Muller-Serieys C, Kafé H.
    Am J Med; 1992 Apr 06; 92(4A):8S-11S. PubMed ID: 1316076
    [Abstract] [Full Text] [Related]

  • 32. Effect of omeprazole on the pharmacokinetics of oral gemifloxacin in healthy volunteers.
    Allen A, Vousden M, Lewis A.
    Chemotherapy; 1999 Apr 06; 45(6):496-503. PubMed ID: 10567781
    [Abstract] [Full Text] [Related]

  • 33. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989 Apr 06; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 34. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.
    Kamberi M, Tsutsumi K, Kotegawa T, Kawano K, Nakamura K, Niki Y, Nakano S.
    Antimicrob Agents Chemother; 1999 Mar 06; 43(3):525-9. PubMed ID: 10049262
    [Abstract] [Full Text] [Related]

  • 35. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E, Bartoletti R, Trinchieri A, Rizzo M.
    J Chemother; 1996 Jun 06; 8(3):210-3. PubMed ID: 8808718
    [Abstract] [Full Text] [Related]

  • 36. [Highperformance liquid chromatographic assay for lomefloxacin in plasma and its pharmacokinetics in healthy volunteers].
    Tan L, Xu DK, Diao Y, Yuan YS.
    Yao Xue Xue Bao; 1993 Jun 06; 28(4):286-9. PubMed ID: 8213172
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec 06; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 38. Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its metabolite ciprofloxacin after intravascular administration of enrofloxacin in goats.
    Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK.
    J Vet Pharmacol Ther; 2000 Dec 06; 23(6):365-72. PubMed ID: 11168914
    [Abstract] [Full Text] [Related]

  • 39. Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.
    Kovarik JM, Hoepelman AI, Smit JM, Sips PA, Rozenberg-Arska M, Glerum JH, Verhoef J.
    Antimicrob Agents Chemother; 1992 Nov 06; 36(11):2458-61. PubMed ID: 1336948
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
    Piersimoni C, Morbiducci V, Bornigia S, De Sio G, Scalise G.
    Am Rev Respir Dis; 1992 Dec 06; 146(6):1445-7. PubMed ID: 1333738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.